Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata in children shows varied forms and treatment challenges, with some achieving full or partial hair regrowth.

Stem cell therapies show promise for hair regrowth in alopecia areata but need more research for safety and effectiveness.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

JAK inhibitors are effective and safe for treating severe alopecia areata.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

Early intervention in patch-type alopecia may prevent progression to more severe forms by targeting immune pathways and preserving keratin.

Colectomy led to hair regrowth in a Crohn's patient with alopecia areata.

Gut microbiota changes might play a role in alopecia areata, and microbiome-targeted treatments show promise.

People with alopecia areata have a higher risk of heart disease.

Alopecia areata patients, especially with severe forms, have a higher risk of cardiovascular disease.

Alopecia areata may increase the risk of cardiovascular disease.

Topical immunotherapy can help with severe hair loss, but results vary and need personalized, long-term treatment.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Tofacitinib effectively regrows hair in alopecia universalis triggered by a virus.

Women with alopecia areata have poor blood flow, possibly due to nerve inflammation.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Alopecia areata causes patchy hair loss due to the immune system attacking hair follicles.

Baricitinib effectively promotes hair regrowth in alopecia areata patients with mild side effects.

A woman experienced total hair loss after an HPV vaccine, but treatment helped regrow her hair.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

Deucravacitinib helped a man regrow hair significantly.

Baricitinib improved hair loss and arthritis in a lupus patient.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.